Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions
Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions
复制标题
DOI：
10.1111/add.14883
复制
发表时间：
2019-12-20
期刊：
影响因子：
6
通讯作者：
Goodwin, Renee D.
中科院分区：
文献类型：
--
作者：
Pacek, Lauren R.;Weinberger, Andrea H.;Goodwin, Renee D.
估计2005年至2017年美国抑郁症患者和非抑郁症患者大麻使用的流行趋势和大麻使用的风险认知。设计线性时间趋势的流行率的任何，日常和非日常过去30天的大麻使用和感知的巨大风险与定期使用大麻（结果变量）的人与无上年抑郁症进行了评估，使用logistic回归调查年作为预测。所有分析都根据性别、年龄、种族/族裔和收入进行了调整;评估大麻使用流行率时间趋势的模型也根据感知风险进行了调整。美国：全国药物使用和健康调查，年度横断面调查，2005-17公共使用数据文件。参与者共有728 691人年龄≥ 12岁。自我报告过去30天内每天和非每天使用大麻的情况，以及与定期使用大麻相关的重大风险。在过去的一个月里，抑郁症患者每日和非每日使用大麻的患病率高于未使用大麻的患者[例如，2017年任何用途：18.94与8.67%;调整后的比值比（aOR）= 2.17（95%置信区间（CI）= 1.92，2.45）]。从2005年到2017年，患有和没有抑郁症的人中，任何、每日和非每日大麻使用量都有所增加，但任何（aOR = 1.06与1.05; P = 0.008）和每日（aOR = 1.10与1.07; P = 0.021）大麻使用量的增加在抑郁症患者中根据社会人口特征进行调整后更快。抑郁症患者对定期使用大麻相关的巨大风险的感知显著较低（P < 0.001），并且在研究期间，与没有抑郁症的人相比，抑郁症患者的下降速度更快（aOR = 0.89 vs 0.92; P < 0.001）。从2005年到2017年，美国大麻使用的流行率在有抑郁症和无抑郁症的人群中有所增加，并且在抑郁症患者中大约是两倍。抑郁症患者对风险的感知下降得更快，这可能与该组中任何和每日上个月大麻使用的快速增加有关。
Aims To estimate trends in the prevalence of cannabis use and risk perceptions of cannabis use from 2005 to 2017 among United States people with and without depression. Design Linear time trends of the prevalence of any, daily and non-daily past 30-day cannabis use and perceived great risk associated with regular cannabis use (outcome variables) among people with and without past-year depression were assessed using logistic regression with survey year as the predictor. All analyses were adjusted for gender, age, race/ethnicity and income; models assessing time trends of cannabis use prevalence were also adjusted for perceived risk. Setting The United States: National Survey on Drug Use and Health, an annual cross-sectional survey, 2005-17 public use data files. Participants A total of 728 691 people aged >= 12 years. Measurements Self-report of any, daily and non-daily past 30-day cannabis use and perceived great risk associated with regular cannabis use. Findings The prevalence of any, daily and non-daily cannabis use in the past month was higher among those with depression versus those without [e.g. 2017 for any use: 18.94 versus 8.67%; adjusted odds ratio (aOR) = 2.17 (95% confidence interval (CI) = 1.92, 2.45)]. Any, daily and non-daily cannabis use increased among people with and without depression from 2005 to 2017, yet the increase in any (aORs = 1.06 versus 1.05; P = 0.008) and daily (aORs = 1.10 versus 1.07; P = 0.021) cannabis use adjusted for socio-demographic characteristics was more rapid among those with depression. Perception of great risk associated with regular cannabis use was significantly lower among those with depression (P < 0.001) and decreased significantly more rapidly over the study period among people with depression, compared with those without (aORs = 0.89 versus 0.92; P < 0.001). Conclusions The prevalence of cannabis use in the United States increased from 2005 to 2017 among people with and without depression and was approximately twice as common among those with depression. People with depression experienced a more rapid decrease in perception of risk, which may be related to the more rapid increase in any and daily past-month cannabis use in this group.